Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Jingjing Pharmaceutical Co., Ltd., a subsidiary of Sichuan Kelun Pharmaceutical, is a prominent Chinese pharmaceutical company specializing in the production of active pharmaceutical ingredients (APIs) and finished dosage forms. The company is recognized as a leading global supplier of various amino acids, including L-arginine and L-histidine, as well as specialized chemical intermediates. Operating out of large-scale, GMP-compliant facilities in Shijiazhuang, Jingjing Pharmaceutical serves both domestic and international markets. Its product portfolio spans multiple therapeutic areas such as anti-infectives, respiratory health, and cardiovascular medicine. The company plays a critical role in the global pharmaceutical supply chain through its robust manufacturing capabilities in chemical synthesis and fermentation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jingjing.